Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06047899
Other study ID # 2023-01628
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 28, 2023
Est. completion date May 2, 2024

Study information

Verified date May 2024
Source University of Basel
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this clinical trial is to learn about the effect of the dietary supplement luteolin in healthy people. The main question it aims to answer is: Does luteolin have an influence on memory functions? Participants will go trough two treatment phases. In one phase they will take 250mg luteolin twice daily for two weeks. In the other phase they will take a placebo twice daily for two weeks. A placebo is a look-alike substance that contains no active drug. At the start and end of teach treatment phase, participants will undergo different memory testing exercises in our research facility.


Recruitment information / eligibility

Status Completed
Enrollment 44
Est. completion date May 2, 2024
Est. primary completion date May 2, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria: - healthy - male or female - able to give written informed consent as documented by signature - Aged: 18 to 40 years - normotensive (BP 90/60mmHg to 140/90mmHg) - BMI = 30 kg/m2 Exclusion Criteria: - bodyweight <50 kg - pregnant or lactating women - intention to become pregnant during the course of the study - known or suspected non-compliance, drug or alcohol abuse - MADRS-S total score > 12 or MADRS-S item 9 >1 - inability to follow the procedures of the study, e.g. due to language problems, psychological disorders - participation in another study with investigational drug within the 30 days preceding and during the present study - participation in one of our previous studies using the same memory tests in the past 2 years or participation in our first luteolin study in 2020 - enrolment of the investigator, his/her family members, employees and other dependent persons

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Luteolin
Luteolin extracted from Chrysanthemum Ramat 98% HPLC by Scyherb® food grade certified according to Safe Quality Foods (SQF) - Level 3 Comprehensive Food Safety and Quality Management System Certification by the Safe Quality Food Institute (SQFI).
Other:
Placebo
mannitol formulated for oral administration (capsules)

Locations

Country Name City State
Switzerland University of Basel, Division of Cognitive Neuroscience Basel Basel-Stadt

Sponsors (1)

Lead Sponsor Collaborator
Prof. Dominique de Quervain, MD

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Visual Memory Test Performance in a visual memory test (Rey-Osterrieth complex figure test (Rey 1941) and (Osterrieth 1944)). As parallel version we will use the modified complex Taylor figure test (Hubley 2002).
Participants will have to copy the complex figure. After a short delay of 5 minutes, they will be asked to redraw the figure from memory. A long-delayed recall test will be administered 2 weeks after the learning phase.
Performance is calculated by scoring for accuracy and relative position of the 18 units in the whole of the design. Maximal score is 36 points.
short delay (5 minutes), long delay (14 days): to assess differences between these time points
Secondary Verbal Memory Task Verbal memory task (de Quervain, Roozendaal et al. 2000). A parallel version will be used for the second study phase.
Subjects are given explicit instructions to learn 60 unrelated German nouns for immediate and delayed recall. For all free-recall tests (immediate recall, short delay and long delay), subjects will be asked to write down all the words they remember. The number of correctly recalled words (hits) will be the relevant output.
Delayed recall of all 60 words will be tested about 10 min (short delay) and 2 weeks (long delay) after presentation.
immediate recall, short delay (10 minutes), long delay (14 days): to assess differences between these time points
Secondary Working Memory Test Working memory will be assessed with the digit span task backward, a subtest of the "Wechsler Intelligenztest für Erwachsene" (von Aster 2006). A parallel version will be used for each visit. Each correct reproduction of a sequence of numbers is scored with one point. after each treatment phase (duration two weeks)
Secondary Mood State (MDBF) Mood state will be assessed with the self-rating instrument MDBF (Steyer 1997) consisting of 12 items to be rated in a 5 scale mode. The total score is calculated by summing the answers in each of the 3 dimensions good/bad mood, alertness/sleepiness, rest /restlessness with 4 items in each dimension. We will use a parallel version for each visit. after each treatment phase (duration two weeks)
Secondary Depressive Symptoms Depressive symptoms will be assessed with the self-rating questionnaire MADRS-S (Cunningham 2011) (Schmidtke 1988). This scale consists of 9 items assessing participants' mood, feelings of unease, sleep, appetite, ability to concentrate, initiative, emotional involvement, pessimism and zest for life. Each item is scored between 0 and 3. The total score is calculated by summing the answers of the nine items, ranging between 0 and 27 (higher scores indicate increased impairment). after each treatment phase (duration two weeks)
Secondary Anxiety Anxiety will be measured with the self-rating instrument STAI-G form X1 (state) (Laux 1981).This instrument consists of 20 items scored between 1-4. The total score is calculated by summing the answers, ranging between 20 and 80. after each treatment phase (duration two weeks)
Secondary Visual Analog Scales Quality of Sleep Subjective sleep quality is assessed using a visual analogue scale (VAS) in relation to the past two weeks. Respondents specify their level of agreement to the statement by indicating a position along a continuous line (10 cm) between the two end-points: better sleep quality respectively than normal or worse. The score ranges between -5 and + 5. after each treatment phase (duration two weeks)
See also
  Status Clinical Trial Phase
Completed NCT01007682 - Intrusive Reexperiencing: The Role of Working Memory Capacity and Thought Suppression N/A
Completed NCT04330677 - Dissecting the Role of Estradiol in Mediating Gender-specific Anxiolytic and Prosocial Effects of Oxytocin Phase 1
Active, not recruiting NCT04392908 - Communication Memory of Cancer Diagnosis Within the Pediatric Triangle
Recruiting NCT04694534 - Remediation Program Via a "Serious Game" for the Cognitive Functions of Multiple Sclerosis Patients N/A
Completed NCT01159652 - Hypnotic Medications and Memory: Effect of Drug Exposure During the Night Phase 4
Recruiting NCT04598945 - Acquisition and Retention of Motor Memories in Adults and Typically Developing Children N/A
Terminated NCT04021797 - Autonomic Mechanisms of Sleep-dependent Memory Consolidation N/A
Completed NCT04025255 - The Memory and Cognitive Performance Study N/A
Not yet recruiting NCT04103463 - Interactive Stepping Exercise on Memory N/A
Recruiting NCT06351098 - Longitudinal Investigation of Sleep, Memory, and Brain Development Across the Nap Transition Early Phase 1
Recruiting NCT04402294 - Individualized Closed Loop TMS for Working Memory Enhancement N/A
Completed NCT01126229 - Resveratrol for Improved Performance in the Elderly Phase 1
Completed NCT00913640 - Prospective Memory in Parkinson's Disease
Completed NCT03974399 - BDNF Levels After Bacopa N/A
Completed NCT01143194 - A Randomized, Placebo-Controlled, Double-Blind, Crossover Study to Evaluate the Effects of Three Doses of the Dietary Supplement oréVida™ on Alertness, Attention and Concentration in Healthy Men and Women Phase 1
Completed NCT00454454 - Virtual Reality Helmet to Test for Problems With Memory N/A
Completed NCT00584324 - Depth of Anesthesia on Implicit Memory N/A
Completed NCT06074172 - The Effect of Cannabidiol in Learning and Memory of Adults Phase 2
Completed NCT03763409 - Losartan and Emotional Memory N/A
Completed NCT05907707 - Effects of Gamma-tACS on Memory and Sleep N/A